RMB Products Adds Additional 3D Printing Workstations

August 2019 – RMB Products rotomolds, rotolines and 3D prints critical components used in commercial and defense aerospace, semiconductor, biopharma and chemical applications.  Within the last year RMB has made substantial capital investments in all manufacturing areas, including the addition of two new EOS 3D printing workstations with automated powder handling in a closed loop system. These workstations will enhance part repeatability and cleanliness.  RMB utilizes its equipment primarily for the manufacture of aerospace components.  To further expand this capability, RMB ordered two additional new workstations scheduled to be installed in in Q1 2020.

Capital ideas,
delivered to your inbox

Recent Posts
View All

MCM Capital Partners (“MCM”), a micro-cap private equity firm based in Cleveland, Ohio, is pleased to announce its recent acquisition of AIM Processing based in Longmont, CO. AIM Processing is a custom plastic injection molder specializing in small, tight-tolerance parts and are experts in overmolding, insert molding, and metal replacement serving the medical device, industrial,...

Cleveland, OH –MCM Capital Partners (“MCM”), a micro-cap private equity firm based in Cleveland, Ohio, is excited to announce the majority recapitalization of Tech NH, Inc. (“Tech” or the “Company”). Tech, based in Merrimack, New Hampshire, is a technical injection molder serving the medical device, general industrial, defense and green energy industries. Founded in 1982...

As a private equity fund focused on lower middle market manufacturing and distribution businesses, we are often asked about our eventual plans to sell portfolio companies. Private equity investors typically have a planned investment horizon (typically 5-7 years) during which they expect to hold, grow and exit a portfolio company. However, the exact timing of...

Partnering with a private equity fund is sure to have a transformative effect on any business. Gaining clarity on these topics will help determine whether a private equity suitor can be a potential long-term growth partner.